Hypothesis: Biomarkers, commonly expressed in breast cancer cells, may be correlated with their expression in breast skin of the same subjects. Methods: The expression of biomarkers in specimens from 33 breast tumours and breast skin from the same subject and from 32 normal controls was studied using immunohistochemical techniques. Results: (1) In normal women, there are significant correlations between the levels of expression of cyclin D1, bcl-2 and p53 in normal breast epithelial cells and breast skin epithelial cells. (2) These patterns of biomarker expression in normal women are similar in breast cancer and breast skin epithelial cells of women with invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS), but are at significantly higher levels in both breast cancer cells and skin from the same subjects. (3) In normal women, human epidermal growth factor receptor 2 (HER-2) is not expressed in either breast epithelial cells or skin epithelial cells. (4) HER-2 is expressed in the breast skin of some subjects with HER-2-positive breast cancer. (5) Positive oestrogen receptor alpha expression occurs significantly more frequently in the breast skin of women with IDC and DCIS than in normal controls. Conclusion: The influence of localised breast cancer seems to be systemic, and leads to changes in skin and hair.A bnormal x ray diffraction patterns have been observed in the hair of women with breast cancer.1 2 Although this finding has been disputed, it is biologically plausible that the abnormal hormone receptor and oncogene expression commonly associated with carcinogenesis in breast tissues may also occur in skin tissues and are associated with changes in hair.3 4 This biological plausibility is based on the following: (1) breasts are specialised sweat glands that originate in skin, (2) hair also originates in skin; and (3) oestrogen and other hormones are metabolised in skin and hair follicles. Oestrogen receptor alpha (ERa), progesterone receptors, B cell lymphoma (bcl)-2, human epidermal growth factor receptor-2 (HER-2/neu or c-erbB2), cyclin D1 and p53 proteins are abnormally highly expressed in many breast cancer tumours. [6][7][8][9][10][11][12] Oestrogen and progesterone receptors are hormone receptors associated with cell growth; cyclin D1 is associated with cell replication; bcl-2 and p53 are regarded as tumour suppressor genes; and HER-2 is regarded as an oncogene. However, the roles of these receptors and genes are more complex than indicated by these simple role definitions.We hypothesised that the expression of these biomarkers in breast cancer cells may be correlated with their expression in breast skin of the same subjects. To test this hypothesis, we studied the expression of these biomarkers in breast tissues and breast skin of 23 patients with invasive ductal breast carcinoma (IDC), 10 patients with ductal carcinoma in situ (DCIS) and 32 normal subjects. We have shown that this hypothesis may be correct.
METHODSArchival formalin-fixed, paraffin-wax-mounted, open breast biopsy specim...